IRADIMED CORP
For the period ended Dec 31, 2025. Filed Mar 6, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 6, 2026
IRMD$86.94+0.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Statements of Cash Flows
| | | | | | | | | |
|---|---|---|---|---|---|---|---|---|
| · · · Year Ended | ||||||||
| · · · December 31, | ||||||||
| · · · 2025 · · 2024 | ||||||||
| Operating activities: · · · · · · · | ||||||||
| Net income | | | | $22,480 | | $19,234 | ||
| Adjustments to reconcile net income to net cash provided by operating activities: | | | | | | | | |
| Allowance for credit losses | | | | (84) | | (95) | ||
| Provision for excess and obsolete inventory | | | | 47 | | 88 | ||
| Depreciation & amortization | | | | 1,166 | | 818 | ||
| Loss on disposal of property and equipment | | | | 37 | | 4 | ||
| Stock-based compensation | | | | 2,919 | | 2,524 | ||
| Deferred income taxes, net | | | | 2,727 | | (698) | ||
| Changes in operating assets and liabilities: | | | | | | | | |
| Accounts receivable | | | | (3,027) | | 1,762 | ||
| Inventory | | | | (1,377) | | 3,126 | ||
| Prepaid income taxes | | | | | (2,575) | | | (786) |
| Prepaid expenses and other current assets | | | | (132) | | (320) | ||
| Other assets | | | | (40) | | (17) | ||
| Accounts payable | | | | (76) | | (862) | ||
| Accrued payroll and benefits | | | | (554) | | 997 | ||
| Other accrued taxes | | | | 150 | | 60 | ||
| Warranty reserve | | | | 26 | | 1 | ||
| Deferred revenue | | | | 1,596 | | (111) | ||
| Other current liabilities | | | | (150) | | (100) | ||
| Accrued income taxes | | | | 1,814 | | — | ||
| Net cash provided by operating activities | | | | | 24,947 | | 25,624 | |
| Investing activities: | | | | | | | ||
| Purchases of property and equipment | | | | (7,765) | | (8,005) | ||
| Capitalized intangible assets | | | | (656) | | (812) | ||
| Net cash used in investing activities | | | | | (8,421) | | (8,817) | |
| Financing activities: | | | | | | | ||
| Dividends paid | | | | (15,040) | | (13,677) | ||
| Proceeds from exercises of stock options | | | | — | | 29 | ||
| Taxes paid related to the net share settlement of equity awards | | | | (2,561) | | (688) | ||
| Net cash used in financing activities | | | | (17,601) | | (14,336) | ||
| Net (decrease) increase in cash and cash equivalents | | | | | (1,075) | | 2,472 | |
| Cash and cash equivalents, beginning of period | | | | 52,234 | | 49,762 | ||
| Cash and cash equivalents, end of period | | | | $51,159 | | $52,234 | ||
| Supplemental disclosure of cash flow information: | | | | | | | ||
| Cash paid for income taxes | | | | $3,923 | | $6,512 | ||
| ROU asset and liability adjustment | | | | $— | | $1,486 | ||
| Operating and short-term lease payments recorded within cash flow provided by operating activities | | | | $489 | | $817 | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.